Dimitriadis Savvas, Dova Lefkothea, Kotsianidis Ioannis, Hatzimichael Eleftheria, Kapsali Eleni, Markopoulos Georgios S
Hematology Laboratory, Unit of Molecular Biology and Translational Flow Cytometry, University Hospital of Ioannina, 45100 Ioannina, Greece.
Department of Hematology, University Hospital of Alexandroupolis, Democritus University of Thrace, 69100 Alexandroupolis, Greece.
Methods Protoc. 2024 Mar 23;7(2):28. doi: 10.3390/mps7020028.
Imaging flow cytometry (ImFC) represents a significant technological advancement in the field of cytometry, effectively merging the high-throughput capabilities of flow analysis with the detailed imaging characteristics of microscopy. In our comprehensive review, we adopt a historical perspective to chart the development of ImFC, highlighting its origins and current state of the art and forecasting potential future advancements. The genesis of ImFC stemmed from merging the hydraulic system of a flow cytometer with advanced camera technology. This synergistic coupling facilitates the morphological analysis of cell populations at a high-throughput scale, effectively evolving the landscape of cytometry. Nevertheless, ImFC's implementation has encountered hurdles, particularly in developing software capable of managing its sophisticated data acquisition and analysis needs. The scale and complexity of the data generated by ImFC necessitate the creation of novel analytical tools that can effectively manage and interpret these data, thus allowing us to unlock the full potential of ImFC. Notably, artificial intelligence (AI) algorithms have begun to be applied to ImFC, offering promise for enhancing its analytical capabilities. The adaptability and learning capacity of AI may prove to be essential in knowledge mining from the high-dimensional data produced by ImFC, potentially enabling more accurate analyses. Looking forward, we project that ImFC may become an indispensable tool, not only in research laboratories, but also in clinical settings. Given the unique combination of high-throughput cytometry and detailed imaging offered by ImFC, we foresee a critical role for this technology in the next generation of scientific research and diagnostics. As such, we encourage both current and future scientists to consider the integration of ImFC as an addition to their research toolkit and clinical diagnostic routine.
成像流式细胞术(ImFC)代表了细胞术领域一项重大的技术进步,它有效地将流式分析的高通量能力与显微镜的详细成像特性结合在一起。在我们的全面综述中,我们采用历史视角来梳理ImFC的发展历程,突出其起源、当前的技术水平,并预测未来可能的进步。ImFC的起源源于将流式细胞仪的液压系统与先进的相机技术相结合。这种协同耦合有助于在高通量规模下对细胞群体进行形态分析,有效地改变了细胞术的格局。然而,ImFC的应用遇到了障碍,尤其是在开发能够管理其复杂的数据采集和分析需求的软件方面。ImFC产生的数据的规模和复杂性需要创建新的分析工具,以便能够有效地管理和解释这些数据,从而使我们能够释放ImFC的全部潜力。值得注意的是,人工智能(AI)算法已开始应用于ImFC,有望增强其分析能力。AI的适应性和学习能力可能在从ImFC产生的高维数据中进行知识挖掘方面至关重要,有可能实现更准确的分析。展望未来,我们预计ImFC不仅可能成为研究实验室中不可或缺的工具,而且在临床环境中也是如此。鉴于ImFC提供的高通量细胞术和详细成像的独特组合,我们预见这项技术在下一代科学研究和诊断中将发挥关键作用。因此,我们鼓励当前和未来的科学家考虑将ImFC纳入他们的研究工具包和临床诊断常规中。